Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,295.8
₹63,319 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹28,637.9
₹60,854 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,400.6
₹29,980 Cr
Pharmaceuticals & Drugs
₹1,217.6
₹23,934 Cr
Pharmaceuticals & Drugs
₹604.6
₹5,479 Cr
Pharmaceuticals & Drugs
₹526.5
₹4,840 Cr
Pharmaceuticals & Drugs
₹400.1
₹4,474 Cr
Pharmaceuticals & Drugs
₹157.0
₹4,030 Cr
Pharmaceuticals & Drugs
₹1,309.2
₹747 Cr
Pharmaceuticals & Drugs
₹50.4
₹141 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,295.8
₹12,668 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,217.6
₹6,229 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,400.6
₹4,209 Cr
Pharmaceuticals & Drugs
₹526.5
₹2,423 Cr
Pharmaceuticals & Drugs
₹604.6
₹1,853 Cr
Pharmaceuticals & Drugs
₹400.1
₹624 Cr
Pharmaceuticals & Drugs
₹157.0
₹157 Cr
Pharmaceuticals & Drugs
₹28,637.9
₹5,849 Cr
Pharmaceuticals & Drugs
₹1,309.2
₹362 Cr
Pharmaceuticals & Drugs
₹50.4
₹396 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,295.8
₹1,811 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,400.6
₹816 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,217.6
₹617 Cr
Pharmaceuticals & Drugs
₹604.6
₹217 Cr
Pharmaceuticals & Drugs
₹526.5
₹157 Cr
Pharmaceuticals & Drugs
₹400.1
₹137 Cr
Pharmaceuticals & Drugs
₹157.0
₹93 Cr
Pharmaceuticals & Drugs
₹28,637.9
₹1,201 Cr
Pharmaceuticals & Drugs
₹1,309.2
₹75 Cr
Pharmaceuticals & Drugs
₹50.4
₹6 Cr

You may also like the below Video Courses